Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1080-1094

  Greenblatt, Matthew B ^a   Sargent, Jennifer L ^b   Farina, Giuseppina ^c   Tsang, Kelly ^a   Lafyatis, Robert ^c   Glimcher, Laurie H ^a,d,e   Whitfield, Michael L ^b   Aliprantis, Antonios O ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; COMPARATIVE GENE MAPPING; DISEASE SEVERITY; FIBROBLAST; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; SKIN BIOPSY; SPECIES COMPARISON; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-13; MACROPHAGES; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 84857229277     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.11.024     Document Type: Article

References (57)

1. C.P. Denton, C.M. Black, D.J. Abraham Mechanisms and consequences of fibrosis in systemic sclerosis Nat Clin Pract Rheumatol 2 2006 134 144
2. Y.S. Gu, J. Kong, G.S. Cheema, C.L. Keen, G. Wick, M.E. Gershwin The immunobiology of systemic sclerosis Semin Arthritis Rheum 38 2008 132 160
3. V. Rogai, R.J. Lories, S. Guiducci, F.P. Luyten, M. Matucci Cerinic Animal models in systemic sclerosis Clin Exp Rheumatol 26 2008 941 946
4. A. Milano, S.A. Pendergrass, J.L. Sargent, L.K. George, T.H. McCalmont, M.K. Connolly, M.L. Whitfield Molecular subsets in the gene expression signatures of scleroderma skin [Erratum appeared in PLoS One 2008, 3(10). doi: 10.1371/annotation/05bed72c-c6f6-4685-a732-02c78e5f66c2] PLoS One 3 2008 e2696
5. M.C. Ruzek, S. Jha, S. Ledbetter, S.M. Richards, R.D. Garman A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease Arthritis Rheum 50 2004 1319 1331
6. J.L. Sargent, A. Milano, S. Bhattacharyya, J. Varga, M.K. Connolly, H.Y. Chang, M.L. Whitfield A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity J Invest Dermatol 130 2009 694 705
7. J.L. Sargent, A. Milano, M.K. Connolly, M.L. Whitfield Scleroderma gene expression and pathway signatures Curr Rheumatol Rep 10 2008 205 211
8. L. Chung, D.F. Fiorentino, M.J. Benbarak, A.S. Adler, M.M. Mariano, R.T. Paniagua, A. Milano, M.K. Connolly, B.D. Ratiner, R.L. Wiskocil, M.L. Whitfield, H.Y. Chang, W.H. Robinson Molecular framework for response to imatinib mesylate in systemic sclerosis Arthritis Rheum 60 2009 584 591
9. K. Ellwood-Yen, T.G. Graeber, J. Wongvipat, M.L. Iruela-Arispe, J. Zhang, R. Matusik, G.V. Thomas, C.L. Sawyers Myc-driven murine prostate cancer shares molecular features with human prostate tumors [Erratum appeared in Cancer Cell 2005, 8:485] Cancer Cell 4 2003 223 238
10. J.I. Herschkowitz, K. Simin, V.J. Weigman, I. Mikaelian, J. Usary, Z. Hu, K.E. Rasmussen, L.P. Jones, S. Assefnia, S. Chandrasekharan, M.G. Backlund, Y. Yin, A.I. Khramtsov, R. Bastein, J. Quackenbush, R.I. Glazer, P.H. Brown, J.E. Green, L. Kopelovich, P.A. Furth, J.P. Palazzo, O.I. Olopade, P.S. Bernard, G.A. Churchill, T. Van Dyke, C.M. Perou Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biol 8 2007 R76
11. A. Sweet-Cordero, S. Mukherjee, A. Subramanian, H. You, J.J. Roix, C. Ladd-Acosta, J. Mesirov, T.R. Golub, T. Jacks An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis Nat Genet 37 2005 48 55
12. J.S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, J.K. Reddy, S.S. Thorgeirsson Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 2004 1306 1311
13. S.A. Pendergrass, R. Lemaire, I.P. Francis, J.M. Mahoney Jr, R. Lafyatis, M.L. Whitfield Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies J Investig Dermatol 2012 10.1038/jid.2011.472
14. N. Noben-Trauth, L.D. Shultz, F. Brombacher, J.F. Urban Jr, H. Gu, W.E. Paul An interleukin 4 (IL-4) independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice Proc Natl Acad Sci USA 94 1997 10838 10843
15. G.J. McKenzie, C.L. Emson, S.E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, A.N. McKenzie Impaired development of Th2 cells in IL-13-deficient mice Immunity 9 1998 423 432
16. L.A. Murray, R.L. Argentieri, F.X. Farrell, M. Bracht, H. Sheng, B. Whitaker, H. Beck, P. Tsui, K. Cochlin, H.L. Evanoff, C.M. Hogaboam, A.M. Das Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2 Int J Biochem Cell Biol 40 2008 2174 2182
17. C.J. Bult, J.T. Eppig, J.A. Kadin, J.E. Richardson, J.A. Blake The Mouse Genome Database (MGD): mouse biology and model systems Nucleic Acids Res 36 2008 D724 D728
18. M.B. Eisen, P.T. Spellman, P.O. Brown, D. Botstein Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 1998 14863 14868
19. V.G. Tusher, R. Tibshirani, G. Chu Significance analysis of microarrays applied to the ionizing radiation response [Erratum appeared in Proc Natl Acad Sci USA 2001, 98:10515] Proc Natl Acad Sci USA 98 2001 5116 5121
20. G. Dennis Jr, B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, R.A. Lempicki DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol 4 2003 P3
21. E. Segal, M. Shapira, A. Regev, D. Pe'er, D. Botstein, D. Koller, N. Friedman Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data Nat Genet 34 2003 166 176
22. P. Clements, P. Lachenbruch, J. Siebold, B. White, S. Weiner, R. Martin, A. Weinstein, M. Weisman, M. Mayes, D. Collier Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis J Rheumatol 1995 1281 1285
23. X. Wang, B. Seed A PCR primer bank for quantitative gene expression analysis Nucleic Acids Res 31 2003 e154
24. O. Bachar, A.C. Rose, M. Adner, X. Wang, C.E. Prendergast, A. Kempf, N.P. Shankley, L.O. Cardell TNF alpha reduces tachykinin, PGE2-dependent, relaxation of the cultured mouse trachea by increasing the activity of COX-2 Br J Pharmacol 144 2005 220 230
25. L. Brys, A. Beschin, G. Raes, G.H. Ghassabeh, W. Nol, J. Brandt, F. Brombacher, P. De Baetselier Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection J Immunol 174 2005 6095 6104
26. P.C. Fulkerson, C.A. Fischetti, L.M. Hassman, N.M. Nikolaidis, M.E. Rothenberg Persistent effects induced by IL-13 in the lung Am J Respir Cell Mol Biol 35 2006 337 346
27. T.A. Wynn IL-13 effector functions Annu Rev Immunol 21 2003 425 456
28. M. Hasegawa, S. Sato, T. Nagaoka, M. Fujimoto, K. Takehara Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma Dermatology 207 2003 141 147
29. T.L. McGaha, C.A. Bona Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma Autoimmun Rev 1 2002 174 181
30. B. Granel, C. Chevillard, Y. Allanore, V. Arnaud, S. Cabantous, S. Marquet, P.J. Weiller, J.M. Durand, J.R. Harle, C. Grange, Y. Frances, P. Berbis, J. Gaudart, P. de Micco, A. Kahan, A. Dessein Evaluation of interleukin 13 polymorphisms in systemic sclerosis Immunogenetics 58 2006 693 699
31. P. Fuschiotti, T.A. Medsger Jr, P.A. Morel Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis Arthritis Rheum 60 2009 1119 1128
32. E.Y. Kim, J.T. Battaile, A.C. Patel, Y. You, E. Agapov, M.H. Grayson, L.A. Benoit, D.E. Byers, Y. Alevy, J. Tucker, S. Swanson, R. Tidwell, J.W. Tyner, J.D. Morton, M. Castro, D. Polineni, G.A. Patterson, R.A. Schwendener, J.D. Allard, G. Peltz, M.J. Holtzman Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease Nat Med 14 2008 633 640
33. G.K. Hershey IL-13 receptors and signaling pathways: an evolving web J Allergy Clin Immunol 111 2003 677 690 quiz 691
34. N. Zimmermann, M.P. Doepker, D.P. Witte, K.F. Stringer, P.C. Fulkerson, S.M. Pope, E.B. Brandt, A. Mishra, N.E. King, N.M. Nikolaidis, M. Wills-Karp, F.D. Finkelman, M.E. Rothenberg Expression and regulation of small proline-rich protein 2 in allergic inflammation Am J Respir Cell Mol Biol 32 2005 428 435
35. F.O. Martinez, L. Helming, S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
36. K.L. Choi, R. Giorno, H.N. Claman Cutaneous mast cell depletion and recovery in murine graft-vs-host disease J Immunol 138 1987 4093 4101
37. R.E. Ellsworth, D.J. Decewicz, C.D. Shriver, D.L. Ellsworth Breast cancer in the personal genomics era Curr Genomics 11 2010 146 161
38. R.A. Okimoto, R.A. Van Etten Navigating the road toward optimal initial therapy for chronic myeloid leukemia Curr Opin Hematol 18 2011 89 97
39. L. Zhou, D. Askew, C. Wu, A.C. Gilliam Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma J Invest Dermatol 127 2007 281 292
40. M.R. York, T. Nagai, A.J. Mangini, R. Lemaire, J.M. van Seventer, R. Lafyatis A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists [Erratum appeared in Arthritis Rheum 2007, 56:1675] Arthritis Rheum 56 2007 1010 1020
41. G. Farina, D. Lafyatis, R. Lemaire, R. Lafyatis A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis Arthritis Rheum 62 2010 580 588
42. V. Riccieri, T. Rinaldi, A. Spadaro, R. Scrivo, F. Ceccarelli, M.D. Franco, E. Taccari, G. Valesini Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities Clin Rheumatol 22 2003 102 106
43. A.O. Aliprantis, J. Wang, J.W. Fathman, R. Lemaire, D.M. Dorfman, R. Lafyatis, L.H. Glimcher Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13 Proc Natl Acad Sci USA 104 2007 2827 2830
44. S. Fichtner-Feigl, W. Strober, K. Kawakami, R.K. Puri, A. Kitani IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis Nat Med 12 2006 99 106
45. J.A. Belperio, M. Dy, M.D. Burdick, Y.Y. Xue, K. Li, J.A. Elias, M.P. Keane Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis Am J Respir Cell Mol Biol 27 2002 419 427
46. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 2004 583 594
47. G. Gallina, L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M.P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, S. Bicciato, V. Bronte Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells J Clin Invest 116 2006 2777 2790
48. D.R. Herbert, C. Hlscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, B. Claussen, I. Frster, F. Brombacher Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology [Erratum appeared in Immunity 2004, 21:455] Immunity 20 2004 623 635
49. M. Hasegawa, S. Sato, K. Takehara Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: mCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis Clin Exp Immunol 117 1999 159 165
50. M. Galindo, B. Santiago, M. Rivero, J. Rullas, J. Alcami, J.L. Pablos Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression Arthritis Rheum 44 2001 1382 1386
51. M.T. Carulli, C. Handler, J.G. Coghlan, C.M. Black, C.P. Denton Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis? Ann Rheum Dis 67 2008 105 109
52. O. Distler, T. Pap, O. Kowal-Bielecka, R. Meyringer, S. Guiducci, M. Landthaler, J. Schlmerich, B.A. Michel, R.E. Gay, M. Matucci-Cerinic, S. Gay, U. Mller-Ladner Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis Arthritis Rheum 44 2001 2665 2678
53. A.M. Ferreira, S. Takagawa, R. Fresco, X. Zhu, J. Varga, L.A. DiPietro Diminished induction of skin fibrosis in mice with MCP-1 deficiency J Invest Dermatol 126 2006 1900 1908
54. M. Hasegawa, S. Sato The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis Front Biosci 13 2008 3637 3647
55. D. Singh, B. Kane, N.A. Molfino, R. Faggioni, L. Roskos, A. Woodcock A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma BMC Pulm Med 10 2010 3
56. J.J. Haringman, D.M. Gerlag, T.J. Smeets, D. Baeten, F. van den Bosch, B. Bresnihan, F.C. Breedveld, H.J. Dinant, F. Legay, H. Gram, P. Loetscher, R. Schmouder, T. Woodworth, P.P. Tak A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis Arthritis Rheum 54 2006 2387 2392
57. C.E. Vergunst, D.M. Gerlag, L. Lopatinskaya, L. Klareskog, M.D. Smith, F. van den Bosch, H.J. Dinant, Y. Lee, T. Wyant, E.W. Jacobson, D. Baeten, P.P. Tak Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial Arthritis Rheum 58 2008 1931 1939